US Senators reintroduce bill to allow cheaper drug imports from Canada

12 January 2015

US Senators Amy Klobuchar (Democrat, Minnesota) and John McCain (Republican, Arizona) last week resumed their fight to reduce prescription drug costs for American families.

The senators reintroduced their bipartisan drug importation legislation, the Safe and Affordable Drugs from Canada Act, that would allow individuals to safely import prescription drugs from Canada, creating major savings for consumers and bringing greater competition into the pharmaceutical market. In 2013, average prescription drug prices were twice as expensive in the USA as they were in Canada, with high costs leading some Americans to skip doses or forgo filling important prescriptions altogether.

“Like many other Americans, far too many Arizonans have been burdened by the rising cost of prescription medication,” said Sen McCain, adding: “No American should have to worry about having to fill a prescription because they can’t afford to pay for it. This legislation would allow individuals to safely import prescription drugs into the United States from our neighbors to the north, spur much-needed competition in the pharmaceutical market, and save individual Americans up to hundreds of dollars a year.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical